Gabelli & Co Investment Advisers’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-115,750	Closed	-$2.47M	–	281
2024 Q1	$2.47M	Buy	+115,750	New	+$1.38M	0.43%	53

Gabelli & Co Investment Advisers's FUSN Position: Q2 2024 in Review

Gabelli & Co Investment Advisers sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 115,750 shares — an estimated $2.47M sold.

Gabelli & Co Investment Advisers first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $2.47M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Gabelli & Co Investment Advisers reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 115,750 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.47M.
Gabelli & Co Investment Advisers first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.47M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2024, filed 13 Aug 2024.